论文部分内容阅读
目的评价米索前列醇联合缩宫素、血凝酶治疗子宫收缩乏力所致的产后出血疗效。方法将300例因产后出血的产妇,随机分为治疗组和对照组各150例,对照组给予缩宫素、注射用白眉蛇毒针等基础治疗,治疗组在对照组基础上加用米索前列醇片治疗,比较2组临床疗效。结果治疗组治愈率为96.7%明显高于对照组的73.3%,差异有统计学意义(P<0.05)。治疗组术后药物止血率、保留子宫率分别为96.7%、100.0%明显高于对照组的73.3%、93.3%,手术治疗率、止血时间明显低于对照组,差异有统计学意义(P<0.05)。结论米索前列醇联合缩宫素、血凝酶治疗产后出血疗效确切,值得临床推广使用。
Objective To evaluate the efficacy of misoprostol in combination with oxytocin and hemagglutinin in the treatment of postpartum hemorrhage caused by uterine atony. Methods 300 cases of postpartum hemorrhage due to postpartum hemorrhage were randomly divided into treatment group and control group of 150 cases, the control group was given oxytocin, injection of white brow snake venom needle and other basic treatment, the treatment group on the basis of the control group with misoprostol Alcohol tablets treatment, the clinical efficacy of two groups were compared. Results The cure rate in the treatment group was significantly higher than that in the control group (96.7% vs 73.3%, P <0.05). The rate of hemostasis and retention of uterus in the treatment group were 96.7% and 100.0%, respectively, which were significantly higher than those in the control group (73.3% and 93.3%, respectively). The rates of surgical treatment and bleeding were significantly lower than those in the control group (P < 0.05). Conclusion Misoprostol combined with oxytocin, hemagglutinin treatment of postpartum hemorrhage curative effect is indeed worthy of clinical promotion and use.